Stay updated on Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5, indicating a new platform release. The change does not alter the study details or visible content on the page.
    Difference
    0.1%
    Check dated 2026-06-05T11:35:47.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a newer build of the page's interface without changes to the study information.
    Difference
    0.1%
    Check dated 2026-05-15T05:31:14.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s displayed software release/revision indicator was updated from v3.5.2 to v3.5.3, reflecting a website version change rather than any modification to the study record.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:17.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible content or functionality changes.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:11.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.0, replacing the previous v3.4.3. No study content or results are impacted.
    Difference
    0.1%
    Check dated 2026-03-19T01:13:35.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T17:48:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Acalabrutinib in NSCLC Clinical Trial page.